Profil
Shobhit Dhawan is a Member-Supervisory Board at Immagene BV.
Previously, he worked as an Investment Manager at AMC Ventures Holding BV from 2015 to 2019.
Postes actifs de Shobhit Dhawan
Sociétés | Poste | Début |
---|---|---|
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Directeur/Membre du Conseil | - |
Anciens postes connus de Shobhit Dhawan
Sociétés | Poste | Fin |
---|---|---|
AMC Ventures Holding BV
AMC Ventures Holding BV Investment ManagersFinance AMC Ventures Holding BV (AMC Ventures) is a venture capital firm, a subsidiary of Academic Medical Center founded in 1995. The firm is headquartered in Amsterdam, the Netherlands. | Private Equity Investor | 01/04/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
AMC Ventures Holding BV
AMC Ventures Holding BV Investment ManagersFinance AMC Ventures Holding BV (AMC Ventures) is a venture capital firm, a subsidiary of Academic Medical Center founded in 1995. The firm is headquartered in Amsterdam, the Netherlands. | Finance |
Immagene BV
Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Health Technology |